We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBAL
3201
DELISTED
Kimball International
KBAL
-287,728
Closed -$3.57M
MGI
3202
DELISTED
MoneyGram International, Inc. New
MGI
-1,455,229
Closed -$15.2M
BRMK
3203
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
-196,549
Closed -$924K
MNTV
3204
DELISTED
Momentive Global Inc. Common Stock
MNTV
-409,624
Closed -$3.82M
AQUA
3205
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-314,140
Closed -$15.6M
RIDE
3206
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
-5,710
Closed -$56.8K
TA
3207
DELISTED
TravelCenters of America LLC
TA
-133,876
Closed -$11.6M
SUMO
3208
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-1,083,884
Closed -$13M
MAXR
3209
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-343,818
Closed -$17.6M
FRC
3210
DELISTED
First Republic Bank
FRC
-2,786,874
Closed -$39M
OSH
3211
DELISTED
Oak Street Health, Inc.
OSH
-275,470
Closed -$10.7M
LMST
3212
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-8,995
Closed -$201K
PRVB
3213
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-154,314
Closed -$3.72M
CSII
3214
DELISTED
Cardiovascular Systems, Inc.
CSII
-437,804
Closed -$8.69M
ATCX
3215
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
-310,520
Closed -$3.79M
AMYT
3216
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
-324,303
Closed -$4.73M
APEN
3217
DELISTED
Apollo Endosurgery, Inc.
APEN
-536,288
Closed -$5.32M
AUY
3218
DELISTED
Yamana Gold, Inc.
AUY
-4,000,703
Closed -$23.4M
DZSI
3219
DELISTED
DZS Inc. Common Stock
DZSI
-29,993
Closed -$237K
CTIC
3220
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-60,459
Closed -$254K
EGLE
3221
DELISTED
Eagle Bulk Shipping Inc.
EGLE
-36,304
Closed -$1.65M
LUNA
3222
DELISTED
Luna Innovations Incorporated
LUNA
-88,005
Closed -$633K
ENV
3223
DELISTED
ENVESTNET, INC.
ENV
-34,483
Closed -$2.02M

Similar funds

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.